Fabless Manufacturing and Use of Partner Companies in the Life Sciences and Equipment Development Business
First written in FY2018. 6 of 9 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2019: 1 of 8 companies on the "Worse" side.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Life Science and Equipment Development Business produces equipment on a fabless basis. To accommodate increases in production volumes and customers’ stringent equipment specifications, the company is focusing on identifying and developing new outsourcing partners, while establishing and strengthening quality control and risk assessment systems to improve stability and reliability.」
Based on fabless production, the company is putting specific measures in place to identify and develop outsourcing partners and strengthen its quality control and risk assessment systems. - FY2022AdvancedAnnual report
「In addition, because the company’s equipment manufacturing uses a fabless model, it is based on the same approach as the production structure of the company’s Life Science and Equipment Development Business. Going forward, the company will strengthen the structure based on its production management expertise and seek to improve manufacturing efficiency.」
The company has extended its fabless production policy to Denshi Kagaku Co., Ltd. and is moving toward strengthening and improving the efficiency of its manufacturing structure based on its production management expertise. - FY2020RestatedAnnual report
「In this business, the company handles development and design in-house for its own products and contract development products, while moving toward a fabless model in which manufacturing is outsourced to external partner companies.」
The company continues its policy of operating a fabless model, with development and design handled in-house and manufacturing handled by partner companies, and of using partner companies. - FY2020-Q3RestatedAnnual report
「The shift in the sales mix from general-purpose equipment using the CELLFLOAT® system, namely CellPet 3D-iPS and CellPet FT, to equipment development projects has also progressed steadily.」
The company continues its operating policy of shifting its sales mix from general-purpose equipment to equipment development projects and using equipment development and contract manufacturing. - FY2019RestatedAnnual report
「In this business, the company handles proposals to users as well as development and design in-house, while moving toward a fabless model in which subsequent manufacturing is outsourced to external partner companies.」
The company continues its fabless model, with proposals, development and design handled in-house and manufacturing handled by partner companies, as well as its use of distributors. - FY2019-Q3RestatedAnnual report
「During the fiscal year, the Company also worked to shift its sales mix from general-purpose equipment using the CELLFLOAT® system, namely CellPet 3D-iPS and CellPet FT, to contract-manufactured products in the equipment development business.」
The company continues its operating policy of shifting its sales mix from general-purpose equipment to contract-manufactured products and using external and contract manufacturing. - FY2019-Q2RestatedAnnual report
「During the fiscal year, the Company also worked to shift its sales mix from general-purpose equipment using the CELLFLOAT® system, namely CellPet 3D-iPS and CellPet FT, to contract-manufactured products in the equipment development business.」
The company continues to shift its sales mix from general-purpose equipment to contract-manufactured products. - FY2019-Q1RestatedAnnual report
「During the fiscal year, the Company worked to shift its sales mix from general-purpose equipment using the CELLFLOAT® system, namely CellPet 3D-iPS and CellPet FT, to contract-manufactured products in the equipment development business.」
The company is shifting its sales mix toward contract-manufactured products in the Equipment Development Business, in line with its operating policy of using external and contract manufacturing. - FY2018First statedAnnual report
「In this business, the company handles proposals to users as well as development and design in-house, while moving toward a fabless model in which subsequent manufacturing is outsourced to external partner companies.」
The company handles proposals, development and design in-house, while moving toward a fabless model in which manufacturing is outsourced to partner companies. The use of distributors and the establishment of maintenance services are also identified as challenges.